These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2400953)

  • 1. Application of recombinant human erythropoietin in oncology.
    Spivak JL
    Cancer Invest; 1990; 8(2):301-2. PubMed ID: 2400953
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of erythropoietin in the treatment of cancer-related anemia].
    Huang JX; Meng FJ
    Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):877-8. PubMed ID: 22335959
    [No Abstract]   [Full Text] [Related]  

  • 3. [Erythropoietin and cancer].
    Pérez Manga G
    Rev Clin Esp; 1992 Mar; 190(5):219-21. PubMed ID: 1579692
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies to optimize the use of erythropoietin and iron therapy in oncology patients.
    Ford PA; Mastoris J
    Transfusion; 2004 Dec; 44(12 Suppl):15S-25S. PubMed ID: 15585001
    [No Abstract]   [Full Text] [Related]  

  • 5. Anemic Gaucher patients with elevated endogenous erythropoietin levels may not respond to recombinant erythropoietin therapy.
    Sidransky E; Ginns EI; Frenkel E; Benear JB
    Blood; 1992 Jan; 79(2):532-3. PubMed ID: 1730096
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum erythropoietin levels in patients with severe anemia secondary to inflammatory bowel disease and the use of recombinant human erythropoietin in patients with anemia refractory to treatment.
    Demirtürk L; Hülagü S; Yaylaci M; Altin M; Ozel M
    Dis Colon Rectum; 1995 Aug; 38(8):896-7. PubMed ID: 7634987
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of recombinant human erythropoietin (rHuEPO) on tumor control in patients with cancer-induced anemia.
    Vaupel P; Dunst J; Engert A; Fandrey J; Feyer P; Freund M; Jelkmann W
    Onkologie; 2005 Apr; 28(4):216-21. PubMed ID: 15840971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin for the treatment of anemia associated with hematological malignancy.
    Littlewood TJ
    Hematol Oncol; 2001 Mar; 19(1):19-30. PubMed ID: 11276043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
    Takashina N; Kondo H; Kashiwazaki S
    J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of erythropoietin in the treatment of patients with oncohematological diseases].
    Lysenko DA; Lutsenko OM
    Lik Sprava; 2005 Jun; (4):69-75. PubMed ID: 16158722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good response of endogenous erythropoietin to blood loss in persistently improving renal anemia after discontinuation of erythropoietin treatment.
    Yabana M; Ikeda Y; Kihara M; Kurita K; Toya Y; Tamura K; Takagi N; Onishi T; Umemura S
    Nephron; 1999 Jan; 81(1):111-2. PubMed ID: 9884433
    [No Abstract]   [Full Text] [Related]  

  • 13. [Role of recombinant erythropoietin during the preoperative period].
    Janssens M; Lamy M
    Ann Fr Anesth Reanim; 1995; 14 Suppl 1():98-106. PubMed ID: 7486323
    [No Abstract]   [Full Text] [Related]  

  • 14. Serial estimation of serum interleukin 6 during treatment with recombinant human erythropoietin in patients with the anemia of rheumatoid arthritis.
    Jongen-Lavrencic M; Swaak AJ; Vreugdenhil G
    J Rheumatol; 1993 Jul; 20(7):1253-5. PubMed ID: 8371234
    [No Abstract]   [Full Text] [Related]  

  • 15. Recombinant erythropoietin for anemia in inflammatory bowel disease.
    Fischer T
    N Engl J Med; 1996 Sep; 335(10):751-2. PubMed ID: 8786771
    [No Abstract]   [Full Text] [Related]  

  • 16. Introduction. Improving the standard of care in the management of cancer-related anaemia: focus on darbepoetin alfa, a novel erythropoiesis-stimulating protein.
    Glaspy J
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):1-2. PubMed ID: 11308267
    [No Abstract]   [Full Text] [Related]  

  • 17. The therapeutic role of recombinant erythropoietin in anemic patients with intact endogenous production of erythropoietin.
    Erslev AJ
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):14-8. PubMed ID: 1615334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin in hematology and oncology. I. Chronic anemia in malignant disease and the pharmacology of erythropoietin].
    Adam Z; Krejcí M; Vorlícek J
    Vnitr Lek; 1996 Apr; 42(4):285-9. PubMed ID: 8693717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Erythropoietin and cancer-related anaemia. Light and shade].
    Otón Sánchez C; Peñate González G; Otón Sánchez LF
    Med Clin (Barc); 2005 Feb; 124(5):186-95. PubMed ID: 15725371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Erythropoietin substitution in anemic patients with rheumatoid arthritis?].
    Bommer J
    Dtsch Med Wochenschr; 1991 Sep; 116(37):1412. PubMed ID: 1889357
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.